Bibliographic Details
| Title: |
Clinical Outcomes of Human Rhinovirus/Enterovirus Infection in Pediatric Hemopoietic Cell Transplant Patients. |
| Authors: |
Castejon-Ramirez, Sandra, Chaisavaneeyakorn, Sujittra, Ferrolino, Jose A, Allison, Kim J, Peterson, Megan, Dallas, Ronald H, Suliman, Ali, Hayden, Randall T, Maron, Gabriela, Hijano, Diego R |
| Source: |
Journal of the Pediatric Infectious Diseases Society; Jan2024, Vol. 13 Issue 1, p75-83, 9p |
| Subject Terms: |
PICORNAVIRUS infections, DISEASE progression, INTENSIVE care units, CAUSES of death, PATIENTS, RETROSPECTIVE studies, RESPIRATORY infections, RISK assessment, ARTIFICIAL respiration, RHINORRHEA, COUGH, RESEARCH funding, DESCRIPTIVE statistics, HEMATOPOIETIC stem cell transplantation, ENTEROVIRUS diseases, TRANSPLANTATION of organs, tissues, etc., CHILD mortality, SYMPTOMS |
| Abstract: |
Background Respiratory viral infections are common among pediatric transplant patients, with human rhinovirus (HRV) being the most frequent. In pediatric patients undergoing hemopoietic cell transplant (HCT), infection with HRV has been associated with progression to lower respiratory tract infection (LRTI) and adverse outcomes. We describe the clinical presentation and outcomes of HRV infection in children undergoing HCT. Methods Single-center retrospective study. HCT recipients who were positive for HRV/EV (HRV+) or negative for any respiratory virus (VN) by BioFire® FilmArray® panel between October 2014 and December 2017, were included. Primary outcomes were progression to LRTI, ICU admission, all-cause mortality at 3 and 6 months, and respiratory event-related mortality at 6 months. Results 227 patients (160 allogeneic HCT) were included. Of all patients, 108/227 (47.6%) were HRV+. From all HRV+, 95/108 (88%) were symptomatic and 68/107 (63.6%) of the diagnosis were made pretransplant. The median age of HRV+ was significantly lower than VN patients (5 vs 10 years). Cough and rhinorrhea were more frequently observed in HRV+ (53.7 and 60% vs 19.8 and 22.8%, respectively). No differences were found between both groups pretransplant and overall in rates progression to LRTI, ICU admission, mechanical ventilation, all-cause within 3 and 6 months, and mortality related with respiratory failure. No significant association was found between the severity of respiratory disease and the type of conditioning, type of transplant, or absolute lymphocyte count. Conclusions HRV infection is frequently detected in HCT recipients but is not associated with severity of respiratory disease, need for intensive care unit or mortality, including those diagnosed before transplant, suggesting that delaying HCT in this scenario may not be needed. Multicenter larger studies are required to confirm these findings. [ABSTRACT FROM AUTHOR] |
|
Copyright of Journal of the Pediatric Infectious Diseases Society is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Complementary Index |
